Products

Portfolio products

Buprenorphine HCl

CAS No.: 53152-21-9

Specification: Ph.Eur & USP

Regulatory Status: CEP + USDMF (applied)

Dexamfetamine sulphate

CAS No.: 51-63-8

Specification: Ph.Eur

Regulatory Status: CEP

Buprenorphine

CAS No.: 52485-79-7

Specification:

Regulatory Status: CEP + USDMF (applied)

Molekyle Lisdex

Lisdexamfetamine dimesylate

CAS No.: 608137-33-3

Specification: N/A

Regulatory Status: DMF

Products under development

Apomorphine HCl

CAS No.: 41372-20-7

Specification: Ph.Eur

Regulatory Status: N/A

Naloxone

CAS No.: 357-08-4

Specification: Ph.Eur

Regulatory Status: N/A

©2023 Chr. Olesen Synthesis